Aegis recently conducted a retrospective analysis of patient samples from individuals who were prescribed buprenorphine to ascertain how frequently novel...
Mental illness is common in the United States, with an estimated 52.9 million people – about 1 in 5 adults...
Healthcare providers rely on medication adherence test results to assist in measuring compliance and evaluating recent substance use. Providers must...
Following the passing of the 2018 Agriculture Improvement Act (a.k.a. Farm Bill), the cannabis industry has seen widespread growth in...
Novel Psychoactive Substances (NPS) are a diverse group of synthetic substances created to mimic the effects of scheduled or illicit...
Nitazene analogs are a subclass of designer opioids that are structurally different from opioids but attach to the same mu-opioid...
Sign up for the Aegis Newsletter